Piedmont Investment Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,431
Closed -$325K 313
2020
Q1
$325K Sell
6,431
-2
-0% -$133 0.01% 573
2019
Q4
$476K Sell
6,433
-1,026
-14% -$64K 0.02% 536
2019
Q3
$426K Buy
7,459
+260
+4% +$17.3K 0.02% 590
2019
Q2
$471K Buy
7,199
+4,105
+133% +$286K 0.02% 572
2019
Q1
$229K Buy
+3,094
New +$218K 0.01% 999
2018
Q3
Sell
-12,267
Closed -$921K 1599
2018
Q2
$921K Buy
12,267
+1,244
+11% +$89.4K 0.04% 319
2018
Q1
$667K Buy
11,023
+454
+4% +$24.6K 0.02% 354
2017
Q4
$493K Sell
10,569
-536
-5% -$26.5K 0.01% 419
2017
Q3
$562K Buy
11,105
+1,520
+16% +$70.8K 0.01% 390
2017
Q2
$478K Buy
+9,585
New +$448K 0.01% 429

Other funds holding HQY

Piedmont Investment Advisors's HQY Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of HealthEquity (HQY) in Q2 2020, closing a stake of 6,431 shares — an estimated $325K sold.

Piedmont Investment Advisors first reported a position in HQY in Q2 2017 and held it in 10 quarters. The position peaked at $921K in Q2 2018. 293 funds tracked by Wall St. Rank hold HQY as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining HealthEquity position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 6,431 HealthEquity shares in Q2 2020, an estimated $325K.
  • Piedmont Investment Advisors first reported a position in HealthEquity in Q2 2017 and held it in 10 quarters.
  • Piedmont Investment Advisors's HealthEquity position peaked at $921K in Q2 2018.
  • 293 funds tracked by Wall St. Rank held HealthEquity as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.